A first case of Chimaeribacter species catheter-related bloodstream infection

Area of Science:

• Microbiology
• Infectious Diseases
• Clinical Case Study

Background:

• The Chimaeribacter genus, a novel addition to the Yersiniaceae family, has an unknown pathogenic profile.
• Clinical data and appropriate antimicrobial strategies for Chimaeribacter infections are currently lacking.
• Catheter-related bloodstream infections (CRBSIs) are a significant concern in healthcare settings.

Purpose of the Study:

• To report the first documented case of a CRBSI caused by Chimaeribacter species.
• To investigate the clinical relevance and pathogenicity of Chimaeribacter species.
• To provide initial antimicrobial susceptibility data for guiding treatment.

Main Methods:

• Case presentation of an 80-year-old patient with CRBSI.
• Identification of the causative agent as Chimaeribacter species.
• Antimicrobial susceptibility testing (AST) was performed.

Main Results:

• Chimaeribacter species was identified as the cause of CRBSI in an elderly patient.
• The study demonstrates the potential clinical significance of this novel genus.
• Antimicrobial susceptibility data for Chimaeribacter species are presented.

Conclusions:

• Chimaeribacter species can cause clinically relevant bloodstream infections.
• This case underscores the need for further research into the pathogenicity and treatment of Chimaeribacter infections.
• The presented antimicrobial susceptibility data offer preliminary guidance for managing such infections.